Login to your account

Username *
Password *
Remember Me
#ESCCongress | In critically ill patients with COVID-19, full-dose anticoagulation reduced thrombotic events but increased the risk of bleeding.

#ESCCongress | In critically ill patients with COVID-19, full-dose anticoagulation reduced thrombotic events but increased the risk of bleeding.

Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients with COVID-19: COVID-PACT – Circulation News Release: Trial supports full-dose anticoagulation to prevent blood clots in COVID-19 patients – European Society of Cardiology Related: Anticoagulants for people hospitalised with COVID‐19 – Cochrane Library Anticoagulation in Patients With COVID-19: JACC Review Topic […]

The post #ESCCongress | In critically ill patients with COVID-19, full-dose anticoagulation reduced thrombotic events but increased the risk of bleeding. appeared first on Links Medicus.

Lu 519 fois
Évaluer cet élément
(0 Votes)

About Author

Recherche